The stimulation of an osteogenic response by classical monocyte activation

Biomaterials

Volumn 32, Issue 32, 2011, Pages 8190-8204

  Omar, Omar M ^a,b   Granéli, Cecilia ^a,b   Ekström, Karin ^a,b   Karlsson, Camilla ^a,b   Johansson, Anna ^a,b   Lausmaa, Jukka ^a,b,c   Wexell, Cecilia Larsson ^a,b,d   Thomsen, Peter ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy   (Sweden)

^c SP TECHNICAL RESEARCH INSTITUTE OF SWEDEN   (Sweden)

^d Public Dental Service   (Sweden)

Author keywords

Cell signalling; Cytokines; Inflammation; Mesenchymal stem cells; Monocytes; Osseointegration

Indexed keywords

CELL SIGNALLING; CYTOKINES; INFLAMMATION; MESENCHYMAL STEM CELLS; MONOCYTES; OSSEOINTEGRATION;

CELL CULTURE; GENES; PHOSPHATASES; POLYSTYRENES; STEM CELLS; SURFACE PROPERTIES; TITANIUM; TRANSCRIPTION; TRANSCRIPTION FACTORS;

BODY FLUIDS;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; POLYSTYRENE; TITANIUM; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE DEVELOPMENT; CELL ACTIVATION; CELL CULTURE MONITORING; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMPLANT; IN VIVO STUDY; MESENCHYMAL STEM CELL; MONOCYTE; OXIDATION; PILOT STUDY; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CULTURE MEDIA, CONDITIONED; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMPLANTS, EXPERIMENTAL; INTERLEUKIN-4; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; MESENCHYMAL STEM CELLS; MONOCYTES; OSTEOGENESIS; SURFACE PROPERTIES; SUS SCROFA;

EID: 80052387310     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.07.055     Document Type: Article

References (61)

1. Sennerby L., Thomsen P., Ericson L.E. Early tissue response to titanium implants inserted in rabbit cortical bone. Part I Light microscopic observations. J Mater Sci Mater Med 1993, 4:240-250.
2. Sennerby L., Thomsen P., Ericson L.E. Early tissue response to titanium implants inserted in rabbit cortical bone. Part II Ultrastructural observations. J Mater Sci Mater Med 1993, 4:494-502.
3. Muller-Mai C.M., Voigt C., Gross U. Incorporation and degradation of hydroxyapatite implants of different surface roughness and surface structure in bone. Scanning Microsc 1990, 4:613-622. discussion 22-4.
4. van Blitterswijk C.A., Grote J.J., Kuypers W., Blok-van Hoek C.J., Daems W.T. Bioreactions at the tissue/hydroxyapatite interface. Biomaterials 1985, 6:243-251.
5. Omar O., Lenneras M., Svensson S., Suska F., Emanuelsson L., Hall J., et al. Integrin and chemokine receptor gene expression in implant-adherent cells during early osseointegration. J Mater Sci Mater Med 2010, 21:969-980.
6. Omar O., Svensson S., Zoric N., Lenneras M., Suska F., Wigren S., et al. In vivo gene expression in response to anodically oxidized versus machined titanium implants. J Biomed Mater Res A 2010, 92:1552-1566.
7. Omar O. Mechanisms of osseointegration: experimental studies on early cellular and molecular events in vivo [Doctoral thesis]. Gothenburg: Univeristy of Gothenburg; 2010.
8. Thomsen P., Gretzer C. Macrophage interactions with modified material surfaces. Curr Opin Solid State Mater Sci 2001, 5:163-176.
9. Gretzer C., Eriksson A.S., Allden B., Ericson L.E., Thomsen P. Monocyte activation on titanium-sputtered polystyrene surfaces in vitro: the effect of culture conditions on interleukin-1 release. Biomaterials 1996, 17:851-858.
10. Gerstenfeld L., Edgar C., Kakar S., Jacobsen K., Einhorn T. Osteogenic growth factors and cytokines and their role in bone repair. Engineering of Functional Skeletal Tissues 2007, 17-45. Springer, London. F. Bronner, M.C. Farach-Carson, A.G. Mikos (Eds.).
11. Champagne C.M., Takebe J., Offenbacher S., Cooper L.F. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone 2002, 30:26-31.
12. Goerdt S., Politz O., Schledzewski K., Birk R., Gratchev A., Guillot P., et al. Alternative versus classical activation of macrophages. Pathobiology 1999, 67:222-226.
13. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
14. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992, 176:287-292.
15. Varin A., Gordon S. Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009, 214:630-641.
16. Song E., Ouyang N., Horbelt M., Antus B., Wang M., Exton M.S. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000, 204:19-28.
17. Stein G.S., Lian J.B., van Wijnen A.J., Stein J.L., Montecino M., Javed A., et al. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 2004, 23:4315-4329.
18. Komori T. Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem 2002, 87:1-8.
19. Cardona M.A., Simmons R.L., Kaplan S.S. TNF and IL-1 generation by human monocytes in response to biomaterials. J Biomed Mater Res 1992, 26:851-859.
20. Green T.R., Fisher J., Stone M., Wroblewski B.M., Ingham E. Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 1998, 19:2297-2302.
21. Gretzer C., Emanuelsson L., Liljensten E., Thomsen P. The inflammatory cell influx and cytokines changes during transition from acute inflammation to fibrous repair around implanted materials. J Biomater Sci Polym Ed 2006, 17:669-687.
22. Kalltorp M., Oblogina S., Jacobsson S., Karlsson A., Tengvall P., Thomsen P. In vivo cell recruitment, cytokine release and chemiluminescence response at gold, and thiol functionalized surfaces. Biomaterials 1999, 20:2123-2137.
23. Pollice P.F., Hsu J., Hicks D.G., Bukata S., Rosier R.N., Reynolds P.R., et al. Interleukin-10 inhibits cytokine synthesis in monocytes stimulated by titanium particles: evidence of an anti-inflammatory regulatory pathway. J Orthop Res 1998, 16:697-704.
24. Omar O.M., Lenneras M.E., Suska F., Emanuelsson L., Hall J.M., Palmquist A., et al. The correlation between gene expression of proinflammatory markers and bone formation during osseointegration with titanium implants. Biomaterials 2011, 32:374-386.
25. Pertoft H., Johnsson A., Warmegard B., Seljelid R. Separation of human monocytes on density gradients of Percoll. J Immunol Methods 1980, 33:221-229.
26. Donath K., Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 1982, 11:318-326.
27. Rifas L. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. J Cell Biochem 2006, 98:706-714.
28. Rifas L., Arackal S., Weitzmann M.N. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J Cell Biochem 2003, 88:650-659.
29. Kodelja V., Muller C., Tenorio S., Schebesch C., Orfanos C.E., Goerdt S. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 1997, 197:478-493.
30. Bocker W., Docheva D., Prall W.C., Egea V., Pappou E., Rossmann O., et al. IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med 2008, 86:1183-1192.
31. Hess K., Ushmorov A., Fiedler J., Brenner R.E., Wirth T. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 2009, 45:367-376.
32. Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000, 141:3956-3964.
33. Gilbert L., He X., Farmer P., Rubin J., Drissi H., van Wijnen A.J., et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 2002, 277:2695-2701.
34. Ding J., Ghali O., Lencel P., Broux O., Chauveau C., Devedjian J.C., et al. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci 2009, 84:499-504.
35. Tintut Y., Patel J., Territo M., Saini T., Parhami F., Demer L.L. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 2002, 105:650-655.
36. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
37. Wise G.E., Frazier-Bowers S., D'Souza R.N. Cellular, molecular, and genetic determinants of tooth eruption. Crit Rev Oral Biol Med 2002, 13:323-334.
38. Kim M.S., Day C.J., Morrison N.A. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem 2005, 280:16163-16169.
39. Kim M.S., Day C.J., Selinger C.I., Magno C.L., Stephens S.R., Morrison N.A. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J Biol Chem 2006, 281:1274-1285.
40. Crisostomo P.R., Wang Y., Markel T.A., Wang M., Lahm T., Meldrum D.R. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008, 294:C675-C682.
41. Novotny N.M., Markel T.A., Crisostomo P.R., Meldrum D.R. Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFkB. Cytokine 2008, 43:215-219.
42. van den Berk L.C., Jansen B.J., Siebers-Vermeulen K.G., Roelofs H., Figdor C.G., Adema G.J., et al. Mesenchymal stem cells respond to TNF but do not produce TNF. J Leukoc Biol 2010, 87:283-289.
43. Jakobsen S.S., Larsen A., Stoltenberg M., Bruun J.M., Soballe K. Hydroxyapatite coatings did not increase TGF-beta and BMP-2 secretion in murine J774A.1 macrophages, but induced a pro-inflammatory cytokine response. J Biomater Sci Polym Ed 2009, 20:455-465.
44. Takebe J., Champagne C.M., Offenbacher S., Ishibashi K., Cooper L.F. Titanium surface topography alters cell shape and modulates bone morphogenetic protein 2 expression in the J774A.1 macrophage cell line. J Biomed Mater Res A 2003, 64:207-216.
45. Takebe J., Ito S., Champagne C.M., Cooper L.F., Ishibashi K. Anodic oxidation and hydrothermal treatment of commercially pure titanium surfaces increases expression of bone morphogenetic protein-2 in the adherent macrophage cell line J774A.1. J Biomed Mater Res A 2007, 80:711-718.
46. Tan K.S., Qian L., Rosado R., Flood P.M., Cooper L.F. The role of titanium surface topography on J774A.1 macrophage inflammatory cytokines and nitric oxide production. Biomaterials 2006, 27:5170-5177.
47. Detmer K., Steele T.A., Shoop M.A., Dannawi H. Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines. Blood Cells Mol Dis 1999, 25:310-323.
48. Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36:1392-1404.
49. Shao L., Frigon N.L., Sehy D.W., Yu A.L., Lofgren J., Schwall R., et al. Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol 1992, 20:1235-1242.
50. Cordonnier T., Langonne A., Sohier J., Layrolle P., Rosset P., Sensebe L., et al. Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum. Tissue Eng Part C Methods 2011, 17:249-259.
51. Albrektsson T., Johansson C., Lundgren A.-K., Sul Y.-T., Gottlow J. Experimental studies on oxidized implants. A histomorphometrical and biomechanical analysis. Appl Osseointegration Research 2000, 1:21-24.
52. Gottlow J., Johansson C., Albrektsson T., Lundgren A.-K. Biomechanical and histologic evaluation of the TiUnite and Osseotite implant surfaces in rabbits after 6 weeks of healing. Appl Osseointegration Research 2000, 1:25-30.
53. Sul Y.T., Johansson C., Albrektsson T. Which surface properties enhance bone response to implants? Comparison of oxidized magnesium, TiUnite, and Osseotite implant surfaces. Int J Prosthodont 2006, 19:319-328.
54. Liu J., Wang S., Zhang P., Said-Al-Naief N., Michalek S.M., Feng X. Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis. J Biol Chem 2009, 284:12512-12523.
55. Mabilleau G., Chappard D., Sabokbar A. Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem 2011, 286:3242-3249.
56. Ochi H., Hara Y., Tagawa M., Shinomiya K., Asou Y. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival. J Orthop Res 2010, 28:657-663.
57. Xing Q., de Vos P., Faas M.M., Ye Q., Ren Y. LPS promotes pre-osteoclast activity by up-regulating CXCR4 via TLR-4. J Dent Res 2011, 90:157-162.
58. Irie N., Takada Y., Watanabe Y., Matsuzaki Y., Naruse C., Asano M., et al. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem 2009, 284:14637-14644.
59. Hayden J.M., Mohan S., Baylink D.J. The insulin-like growth factor system and the coupling of formation to resorption. Bone 1995, 17:93S-98S.
60. Oursler M.J. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta. J Bone Miner Res 1994, 9:443-452.
61. Pederson L., Ruan M., Westendorf J.J., Khosla S., Oursler M.J. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 2008, 105:20764-20769.